000078.SZ
000078.SZ
CNE000000X95
NEPTUNUS
Loading chart...

Company Profile

Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.

Related stocks

002393.SZ
002393.SZ • China
LISHENGPHARMA
14.25 CNY
657.37M USD 1Y -26.5%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.neptunusbio.com

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.6% p.a.
Max Drawdown (5Y)
-75.6%
Sharpe Ratio (5Y)
-0.39
Beta Factor
-0.00
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 550%.
Unprofitable business model: The company is currently generating net losses.
Elevated Short-Term Volatility: 3Y volatility (52.2%) is noticeably higher than the 5Y average (44.6%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.0% in the extended horizon.
ende